[211At]Astatine-Labeled Compound Stability: Issues with Released [211At]Astatide and Development of Labeling Reagents to Increase Stability

Publisher： Bentham Science Publishers

E-ISSN： 1874-4729|1|3|144-176

ISSN： 1874-4710

Source： Current Radiopharmaceuticals, Vol.1, Iss.3, 2008-09, pp. : 144-176

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Astatine-211-Labeled Radiotherapeutics An Emerging Approach to Targeted Alpha-Particle Radiotherapy

By  

Current Pharmaceutical Design, Vol. 6, Iss. 14, 2000-09 ,pp. : 1433-1455

Bentham Science Publishers

Access to resources Recommend Favorite

Astatine-211: Production and Availability

By  

Current Radiopharmaceuticals, Vol. 4, Iss. 3, 2011-07 ,pp. : 177-185

Bentham Science Publishers

Access to resources Recommend Favorite

Targeting EGFR and HER2 with 211At-Labeled Molecules: Unexpected and Expected Dose-Effect Relations in Cultured Tumor Cells

By  

Current Radiopharmaceuticals, Vol. 1, Iss. 3, 2008-09 ,pp. : 225-233

Bentham Science Publishers

Access to resources Recommend Favorite

Stability Issues Related to Nanosuspensions: A Review

By  

Pharmaceutical Nanotechnology, Vol. 1, Iss. 2, 2013-04 ,pp. : 85-92

Bentham Science Publishers

Access to resources Recommend Favorite

The Stability Factor: Importance in Formulation Development

By  

Current Pharmaceutical Biotechnology, Vol. 3, Iss. 4, 2002-01 ,pp. : 361-371

Bentham Science Publishers

Access to resources Recommend Favorite